Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
Teleflex Incorporated (NYSE: TFX) announced that Chairman, President, and CEO Liam Kelly will speak at the Raymond James 42nd Annual Institutional Investors Conference on March 2, 2021, at 12:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) announced that Chairman, President, and CEO Liam Kelly will speak at the Raymond James 42nd Annual Institutional Investors Conference on March 2, 2021, at 12:30 p.m. ET. A live audio webcast and accompanying slides will be accessible on the investor section of Teleflex's website. Teleflex is dedicated to enhancing healthcare through innovative medical technologies across various specialties.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was -0.42%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021 at 12:30 p.m. (ET).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Source:
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.